- Home
- SMRT vs VERV Comparison
SMRT vs VERV Comparison
Compare SMRT & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMRT
- VERV
- Stock Information
- Founded
- SMRT 2017
- VERV 2018
- Country
- SMRT United States
- VERV United States
- Employees
- SMRT N/A
- VERV N/A
- Industry
- SMRT EDP Services
- VERV Medicinal Chemicals and Botanical Products
- Sector
- SMRT Technology
- VERV Health Care
- Exchange
- SMRT Nasdaq
- VERV Nasdaq
- Market Cap
- SMRT 354.2M
- VERV 382.5M
- IPO Year
- SMRT N/A
- VERV 2021
- Fundamental
- Price
- SMRT $1.57
- VERV $6.32
- Analyst Decision
- SMRT Hold
- VERV Strong Buy
- Analyst Count
- SMRT 5
- VERV 4
- Target Price
- SMRT $2.30
- VERV $25.75
- AVG Volume (30 Days)
- SMRT 1.1M
- VERV 1.1M
- Earning Date
- SMRT 11-06-2024
- VERV 11-05-2024
- Dividend Yield
- SMRT N/A
- VERV N/A
- EPS Growth
- SMRT N/A
- VERV N/A
- EPS
- SMRT N/A
- VERV N/A
- Revenue
- SMRT $199,770,000.00
- VERV $24,396,000.00
- Revenue This Year
- SMRT N/A
- VERV $57.08
- Revenue Next Year
- SMRT $7.29
- VERV N/A
- P/E Ratio
- SMRT N/A
- VERV N/A
- Revenue Growth
- SMRT N/A
- VERV 219.91
- 52 Week Low
- SMRT $1.17
- VERV $4.31
- 52 Week High
- SMRT $3.47
- VERV $19.34
- Technical
- Relative Strength Index (RSI)
- SMRT 32.72
- VERV 65.59
- Support Level
- SMRT $1.17
- VERV $6.02
- Resistance Level
- SMRT $1.78
- VERV $6.81
- Average True Range (ATR)
- SMRT 0.10
- VERV 0.42
- MACD
- SMRT -0.02
- VERV 0.06
- Stochastic Oscillator
- SMRT 51.94
- VERV 67.55
About SMRT SmartRent Inc.
SmartRent Inc is an enterprise smart home and smart building technology platform for property owners, managers and residents. The SmartRent solution is designed to provide property managers with seamless visibility and control over all their assets while delivering cost savings and additional revenue opportunities through all-in-one home control offerings for residents. Geographical, it operates in the United States and International; majority revenue being generated from the United States.
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.